|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0030580,
umls-concept:C0030705,
umls-concept:C0034804,
umls-concept:C0034833,
umls-concept:C0034897,
umls-concept:C0037657,
umls-concept:C0185117,
umls-concept:C0208804,
umls-concept:C0349571,
umls-concept:C2911684
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2002-5-23
|
|
pubmed:abstractText |
Patients with recurrent pleomorphic adenomas of the parotid gland are difficult to manage without considerable risk of facial nerve injury. The prognostic significance of progesterone receptor (PR) and estrogen receptor (ER) reported in these adenomas was evaluated in patients with recurrent pleomorphic adenomas, comparing the results in a group of patients with primary adenomas without recurrences during 10 years of follow-up.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Nuclear,
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Somatomedin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2211-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12001119-Adenoma, Pleomorphic,
pubmed-meshheading:12001119-Adolescent,
pubmed-meshheading:12001119-Adult,
pubmed-meshheading:12001119-Aged,
pubmed-meshheading:12001119-Antigens, Nuclear,
pubmed-meshheading:12001119-Child,
pubmed-meshheading:12001119-Female,
pubmed-meshheading:12001119-Humans,
pubmed-meshheading:12001119-Immunoenzyme Techniques,
pubmed-meshheading:12001119-Ki-67 Antigen,
pubmed-meshheading:12001119-Male,
pubmed-meshheading:12001119-Middle Aged,
pubmed-meshheading:12001119-Neoplasm Recurrence, Local,
pubmed-meshheading:12001119-Nuclear Proteins,
pubmed-meshheading:12001119-Parotid Gland,
pubmed-meshheading:12001119-Parotid Neoplasms,
pubmed-meshheading:12001119-Progesterone,
pubmed-meshheading:12001119-Prognosis,
pubmed-meshheading:12001119-Receptors, Estrogen,
pubmed-meshheading:12001119-Receptors, Progesterone,
pubmed-meshheading:12001119-Receptors, Somatomedin
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.
|
|
pubmed:affiliation |
Department of Surgical Oncology, University Hospital Groningen, Groningen, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
